Volume 20 No 8 (2022)
 Download PDF
Correlation between High-Mobility Group Box 1 (HMGB1) and Carcinoembryonic Antigen CEA in Iraqi Colorectal Cancer Patients
Omer Salah Al-Doori, Shatha H. Ali
Abstract
Cancer is a well-known public health problem, and it is a major cause of death worldwide. Colorectal Cancer (CRC), is the most common malignant cancer in the gastrointestinal tract and Carcinoembryonic antigen (CEA) is the most common diagnostic biomarker used in (CRC) and most of the gastric tumors which is used to identify/monitor or detect the type of tumoras it’s used as a predictive and prognostic biomarker.High mobility group box protein-1 (HMGB1) proteins are one of the majorReceptors for Advanced Glycation End Products(RAGE)-ligands that contribute to inflammation consequences and an increased release of RAGE ligands, can play multiple roles in promoting the pathogenesis of (CRC), as it had been heavily implicated in the pathogenesis of (CRC).The research aims to detectthe possible relationship between CEA and HMGB1 in (CRC).
Keywords
Cancer, CRC, CEA, HMGB1
Copyright
Copyright © Neuroquantology

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Articles published in the Neuroquantology are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJECSE right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.